21.06.2016. Synergy, Russian fastest Contract Research Organization (CRO) and Cyntegrity, a German technology provider for efficient Risk-based Monitoring (RBM), are pleased to announce a partnership, in order to foster the practicality of RBM.
Nowadays, the advantages of RBM compared to the traditional monitoring model are recognized by the majority of pharmaceutical companies. Still, challenges appear in most cases when applying the principles of RBM in practice. These challenges are connected with cultural changes within an organization.
Synergy and Cyntegrity initiated a collaboration, in order to address these challenges and apply a risk-friendly environment in practice. This allows making data-driven decisions, improving data quality, achieving earlier data-locks after site closure and be more efficient in clinical trials management.
“Being a 2-year user of Cyntegrity’s cloud-based risk assessment tool, I’m quite impressed with a company’s attitude towards the highest standards of quality and usability. Their goals and objectives are very much in line with our own long-term strategies, so we’d be very pleased to join our efforts and offer our clients more and better services in Russia as well as in Europe”, says Igor Stefanov, Synergy’s CEO.
“Proven technology is an essential component on the way of successful implementation of RBM, nevertheless, the more important element of the equation is a highly professional team, a team, who applies reasonably technology in practice. I am persuaded that in case of Synergy we have found a strong partner to foster the practicality of RBM application”, said Artem Andrianov, Ph.D., Cyntegrity’s CEO.
Synergy Research Group, http://www.synergycro.ru , is a full-service Contract Research Organization (CRO) founded in 2002 that delivers its Troika Promise of Speed, Cost and Quality to clients. The company provides transparency, access and control to sponsors during the entire project through its cloud-based monitoring system. Synergy has locations in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg, Perm, Krasnodar, Almaty and Astana (Kazakhstan) and Kyiv (Ukraine). The company’s headquarters are in Moscow.
Cyntegrity is a leading European RBM technology provider, which offers specialized cloud and SaaS solutions for the efficient Risk-based Monitoring in clinical trials. Cyntegrity’s mission is to offer high-quality analytics that are more predictive than retrospective, which have the ability to integrate the knowledge from previous trials with contextual, real-world data to reduce patient-risk and to optimize preventive care. For more information, visit https://www.cyntegrity.com.